CPSCJanuary 31, 2013consumer

Triaminic and Theraflu Products Recalled Due to Failure to Meet Child-Resistant Closure Requirement; Risk of Poisoning

Official recall recorded by the U.S. Consumer Product Safety Commission.

Recalled product: Triaminic and Theraflu Products Recalled Due to Failure to Meet Child-Resistant Closure Requirement; Risk of Poisoning

The hazard

These child-resistant caps can fail to function properly and enable the cap to be removed by a child with the tamper-evident seal in place, posing a risk of unintentional ingestion and poisoning. These products contain acetaminophen and diphenhydramine which are required by the Poison Prevention Packaging Act to be sealed with child-resistant packaging.

What to do

Consumers should immediately stop using the recalled product and contact Novartis for instructions on how to return the product for a full refund.

Brands named

novartis consumer healthtriaminictriaminic syrupstriaminic and
Read the official CPSC notice →

Recall history

Other federal recalls tied to the same brand — a factual pattern, straight from the source data.

Own something like this?

AllClear screens your whole list against every CPSC, FDA, USDA and NHTSA recall — and tells you the day a new one names something you own.

Start free — 200 items, no card →